LitAlert ~~ GeneLit.com

    • Physicians' experience, practice and education, on genetic testing and genetic counseling: a nationwide survey study in Greece.
    • Fountzilas E, Apostolou P, Vasiliadis AV, Aivazi D, Saloustros E, Fostira F.
    • Fam Cancer. 2022 Jan 24. doi: 10.1007/s10689-022-00290-4. Epub ahead of print.
    • The first case report of a patient with oligodendroglioma harboring CHEK2 germline mutation.
    • Li X, Xue H, Luo N, Han T, Li M, Jia D.
    • Front Genet. 2022 Jan 24;12:718689. doi: 10.3389/fgene.2022.718689.
    • Analysis of BRCA germline mutations in Chinese prostate cancer patients.
    • Chen W, Xia W, Xue S, Huang H, Lin Q, Liu T, Zhang Y, Dong B, Yu Z.
    • Front Oncol. 2022 Jan 24;10:746102. doi: 10.3389/fonc.2022.746102.
    • Exceptional response to lurbinectedin and irinotecan in BRCA-mutated platinum-resistant ovarian cancer patient: a case report.
    • Cortesi L, Venturelli M, Barbieri E, Baldessari C, Bardasi C, Coccia E, Baglio F, Rimini M, Greco S, Napolitano M, Pipitone S, Dominici M.
    • Ther Adv Chronic Dis. 2022 Jan 13;13:20406223211063023. doi: 10.1177/20406223211063023.
    • Durable clinical benefit from PARP inhibition in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case report.
    • Rubinson D, Wolpin BM, Warsofsky IS, Ryan DP, Perez K, Rahma O, Singh H, Yurgelun MB, Shapiro GI, Aguirre AJ, D'Andrea AD, Cleary JM.
    • J Gastrointest Oncol. 2021 Dec;12(6):3133-3140. doi: 10.21037/jgo-21-197.